A 12 week, multi-center, randomized, double-blind, placebo-controlled, parallel, phase II trial to evaluate the efficacy and safety of WIN-34B in patients with Osteoarthritis of the knee
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Anemarrhena asphodeloides/lonicera japonica (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms WIN-34B
- 23 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 May 2013 New trial record